Generic drugmaker says it was pushed to be paid to delay
Credit: iStock/ Savushkin
Generics UK had “little choice” but to enter into a settlement with GlaxoSmithKline in an alleged pay-for-delay scheme, counsel to the generic drugmaker told the Competition Appeal Tribunal today.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now